These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29645259)

  • 1. Involvement of IGF
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-S8. PubMed ID: 29645259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IGF2 and H19 imprinting with choriocarcinoma development.
    Arima T; Matsuda T; Takagi N; Wake N
    Cancer Genet Cytogenet; 1997 Jan; 93(1):39-47. PubMed ID: 9062579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast.
    Walsh C; Miller SJ; Flam F; Fisher RA; Ohlsson R
    Cancer Res; 1995 Mar; 55(5):1111-6. PubMed ID: 7866996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of origin of complete hydatidiform moles.
    Jacobs PA; Wilson CM; Sprenkle JA; Rosenshein NB; Migeon BR
    Nature; 1980 Aug; 286(5774):714-6. PubMed ID: 6447836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer].
    Miyamoto S; Sasaki M; Nishida M; Wake N
    Hum Cell; 1991 Mar; 4(1):38-43. PubMed ID: 1888703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major imprinted gene involved in hydatidiform mole is not located in 2q31.2-qter or 5q34-qter.
    Lund H; Nyegaard M; Svarrer T; Grove A; Sunde L
    Gene; 2012 Apr; 497(2):280-4. PubMed ID: 22336177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.
    Sunde L; Lund H; J Sebire N; Grove A; Fisher RA; Niemann I; Kjeldsen E; Andreasen L; Hansen ES; Bojesen A; Bolund L; Nyegaard M
    Medicine (Baltimore); 2015 Nov; 94(44):e1776. PubMed ID: 26554776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast.
    Mutter GL; Stewart CL; Chaponot ML; Pomponio RJ
    Am J Hum Genet; 1993 Nov; 53(5):1096-102. PubMed ID: 7692725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
    Constância M; Dean W; Lopes S; Moore T; Kelsey G; Reik W
    Nat Genet; 2000 Oct; 26(2):203-6. PubMed ID: 11017078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenomic studies of hydatiform moles and gestational choriocarcinoma].
    Poaty H; Coullin P; Leguern E; Dessen P; Valent A; Afoutou JM; Peko JF; Candelier JJ; Gombé-Mbalawa C; Picard JY; Bernheim A
    Bull Cancer; 2012 Sep; 99(9):827-43. PubMed ID: 22877883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressed alleles of imprinted IGF2, DLK1 and MEG3 colocalize in 3D-preserved nuclei of porcine fetal cells.
    Lahbib-Mansais Y; Barasc H; Marti-Marimon M; Mompart F; Iannuccelli E; Robelin D; Riquet J; Yerle-Bouissou M
    BMC Cell Biol; 2016 Oct; 17(1):35. PubMed ID: 27716032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation of imprinting in trophoblastic disease.
    Ariel I; Lustig O; Oyer CE; Elkin M; Gonik B; Rachmilewitz J; Biran H; Goshen R; de Groot N; Hochberg A
    Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.